Kolkatat, June 14: Ipca Laboratories has recorded 93 per cent increase in net profit at Rs 61.86 crore during 2002-03 as against Rs 32.02 crore registered during the previous year. The total income of the company went up by 16 per cent to Rs 484.52 crore as compared to Rs 416.89 crore in 2001-02, a company release said here on Friday.
The Board has recommended a dividend of 90 per cent (55 per cent) for 2002-03.
The company has improved its export performance by 20 per cent to Rs 278.21 crore during 2002-03 over Rs 231.28 crore earned in the previous year, it said.

Ipca Laboratories has recently incorporated a wholly owned subsidiary in Brazil to tap its growing pharma market.
Besides, the company was also in the process of incorporating another wholly owned subsidiary in the US, it said.
Bureau Report